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The clastogenic effect of total dichloromethane, methanol and water extracts, four bioac-
tive fractions and three individual constituents from Carthamus lanatus aerial parts were
evaluated in mice by bone marrow chromosome aberration assay with mitomycin C as posi-
tive control. Significant differences in the percentage of aberrant mitosis of the extracts were
observed. The dichloromethane extract exhibited a considerable clastogenic effect and the
water extract a negligible one. Different types of chromosome aberrations and time-depen-
dant effects for the active fractions and individual compounds were found.
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Introduction
Carthamus lanatus L. (Asteraceae) is known as
a plant of phytopharmaceutical importance with
sedative, anti-tumor and interferon-inducing activ-
ities (Benedi et al., 1986; Yasuhuko et al., 1979).
Recently, a variety of biological activities of C. la-
natus, including antioxidant, antibacterial, anti-
fungal activity and cytotoxicity were shown (Tas-
kova et al., 2002, 2003; Mitova et al., 2003). Until
now, the clastogenic effect of the species has not
been studied. Some data about the closely related
C. tinctorius were reported. Ames test and Salmo-
nella microsome reversion assay (Morimoto et al.,
1982) showed a mutagenic effect of the water ex-
tract of C. tinctorius flowers, which was confirmed
by Esmaili-rad et al. (1995). Yin et al. (1991) de-
monstrated that the water extract was negative in
the Ames test but positive in the chromosomal ab-
erration and micronucleus assay in mice. The re-
sults of Nobakht et al. (2000) indicated harmful
effects on cellular growth and differentiation dur-
ing the embryonic development.
In the present paper, the clastogenic effect of
three total extracts of C. lanatus, as well as their
bioactive fractions and main individual constitu-
ents, was evaluated in mice using a bone marrow
chromosome aberration assay.
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Experimental
Plant material
Aerial parts of Carthamus lanatus L. (Astera-
ceae) were collected in July at the Losen village re-
gion, Sofia. A voucher specimen (No 156639) is de-
posited in theHerbarium of the Institute of Botany,
Bulgarian Academy of Sciences (SOM). The plant
was collected and identified by Dr. Rilka Taskova.
Extraction and isolation of fractions and
constituents
Dichloromethane extract
Dry and ground aerial parts of C. lanatus
(1.5 kg) were extracted with dichloromethane
(15 l). The dry residue of the extract (29 g) was
partitioned between upper (13 g) and lower (13 g)
layer of hexane/methanol/water (19:19:2, v/v/v).
5 g of the lower layer were separated on silica gel
(Merck) column with hexane and hexane/ethyl-
acetate (20:1 to 1:10). Crude fractions 53Ð57
(31 mg; sterol mixture), fractions 62Ð64 (90 mg;
fraction B; Rf of oleanolic acid on TLC) and frac-
tions 77Ð91 (2.7 g; α-bisabolol fucopyranoside)
were separated and further purified by SEP-Pak
C18 cartridges for rapid sample preparation
(Waters, Milford, USA) with methanol.
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MeOH extract
Dry ground aerial parts (1.5 kg) were extracted
with methanol. The dry residue of the extract
(160 g) was successively extracted with diethyl
ether (18 g), ethyl acetate (4 g) and butanol (9 g);
water part (110 g). The ethyl acetate and butanol
fractions were further separated by droplet
counter current chromatography and column
chromatography on silica gel (Merck) to yield the
flavonoid constituents. The methanol extract, the
ethyl acetate fraction, its main constituent, luteolin
7-O-glucoside, and a minor bioactive constituent,
rutin, were tested.
Water extract
100 g dried aerial parts were extracted with hot
water, concentrated (15 g) and separated on Se-
phadex G-25 (Pharmacia) with water. The water
extract and the low-molecular water fraction (M <
103) (610 mg) were subjected to the analysis.
Animals
Male and female ICR mice weighing 20 g ð
1.5 g were obtained from the Base for Experimen-
tal Animals, BAS, Slivnitza. The animals were kept
at standard conditions at 20 ∞C and 12 h light-dark
cycle, having free access to food and water. Ex-
periments were performed in accordance with the
current guidelines for the care of laboratory ani-
mals.
Chromosome aberrations
The investigation was performed according to
Preston et al. (1987). The samples were adminis-
tered intraperitoneally (i. p.) at a dose of 1 mg/kg.
Mitomycin C (Kyowa, Tokyo, Japan) (1 mg/kg)
was used as a positive control. The control animals
were injected with 0.2 ml solvent solution
(DMSO) or 0.9% NaCl.
The bone marrow chromosome aberration assay
was performed on groups of animals consisted of
5 males and 5 females, which were treated with
the samples, the DMSO solvent, 0.9% NaCl and
the positive control, respectively. The animals
were injected i. p. with colchicine at a dose of
0.4 mg/kg 24 h and 48 h after administration of the
samples, of DMSO, of mitomycin C (MMC) or
0.9% NaCl, respectively, and 1 h before isolation
of the bone marrow cells. The sampling times were
chosen to ensure the cell analysis in case of a con-
siderable mitotic delay. Mice were euthanized,
bone marrow cells flushed from femur and hypo-
tonized in 0.075 m KCl at 37 ∞C for 20 min. The
cells were fixed in methanol/acetic acid (3:1),
dropped on cold slides and air-dried. The slides
were stained with 5% Giemsa solution (Sigma,
St. Louis, USA). At least 50 well-spread meta-
phases were analysed per experimental animal at
random.
Statistical analysis
Three-way analysis of variance (ANOVA) with
fixed effects, followed by two-group Student’s t-
test and post hoc pairwise comparison test of
Dunnett with a control was performed using
BMDP4V, BMDP3D and BMDP7D programs
(Dixon et al., 1990).
Results and Discussion
Three total extracts with different polarity
(CH2Cl2, MeOH and H2O extracts), four bioactive
fractions and three main constituents were sub-
jected to analysis of chromosomal aberrations in
mitotic chromosomes of mouse bone marrow cells
at a dose of 1 mg/kg. The tested fractions and con-
stituents were chosen on the ground of proven
biological activities. The sterol fraction and frac-
tion B showed significant cytotoxicity assessed by
the brine shrimp assay (Mitova et al., 2003). The
ethyl acetate fraction and its main constituent, lu-
teolin 7-O-glucoside, exhibited cytotoxic and anti-
oxidant activities (Taskova et al., 2002, 2003). The
low-molecular water fraction possessed cytotoxic
activity and antimicrobial activity against Staphy-
lococcus aureus (Taskova et al., 2002).
The obtained data were presented in protocols
according to Preston et al. (1987) and summarized
in Table I. The solvent, dimethyl sulfoxide
(DMSO) (0.01 ml/g) caused statistically insignifi-
cant increase of the percentage of aberrant mitosis
vs. the control (0.9% NaCl). The positive control,
mitomycin C (MMC) (1 mg/kg) caused 12.8 ð
0.8% aberrations 24 h after administering. After
48 h the percentage decreased to 5.0 ð 0.33, which
is in agreement with the time-dependent fre-
quencies of aberrations after a single injection of
1 mg/kg MMC described by Hayashi et al. (1984).
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Table I. Frequencies of chromosome aberrations in affected mouse bone marrow cells after i.p. treatment of fractions
and constituents of Carthamus lanatus aerial partsa.
Percentage
Sampleb Interval Type of aberrations of cells with Statistical Statistical
[h] Breaks Fragments c/c t/t aberrations significancec significanced
X ð s.e.m.
Dichloromethane extract 24 16 8 24 2 10.0 ð 0.86 **
48 12 4 18 8 8.4 ð 0.97 ** *
Sterol fraction 24 11 9 6 0 6.5 ð 0.73 ** **
48 3 4 9 0 3.2 ð 0.53 *
Fraction B 24 4 0 10 0 2.8 ð 0.32
48 13 0 7 0 4.0 ð 0.61 ** **
α-Bisabolol fucopyranoside 24 9 5 0 0 2.6 ð 0.42 **
48 7 15 0 2 5.6 ð 0.40
MeOH extract 24 6 8 16 2 6.8 ð 0.43 ** **
48 4 1 22 1 5.6 ð 0.39 **
Ethyl acetate fraction 24 8 0 16 0 4.8 ð 0.53 ** **
48 7 0 13 0 2.6 ð 0.42
Luteolin 7-O-glucoside 24 8 3 18 0 5.4 ð 1.16 ** **
48 14 6 13 0 6.8 ð 1.08 **
Rutin 24 0 0 0 0 0.6 ð 0.30 **
48 5 0 15 0 4.2 ð 0.46 **
Water extract 24 4 0 11 1 3.2 ð 0.49 ** **
48 2 0 8 0 2.0 ð 0.63 **
Low-molecularwater fraction 24 5 0 7 0 2.8 ð 0.44
48 1 0 8 0 1.8 ð 0.36
Solvent: DMSO 24 1 1 4 0 1.4 ð 0.30 control **
48 2 0 2 0 0.8 ð 0.32 control **
Control: 0.9% NaCl 24 1 0 2 0 0.6 ð 0.30 **
48 0 0 3 0 0.6 ð 0.30 **
Mitomycin C 24 31 24 9 0 12.8 ð 0.8 ** control
48 10 13 0 0 5.0 ð 0.33 ** control
a Number of methaphases scored 500.
b Dose of 1 mg/kg.
c Dunnet control group comparison test with DMSO as a control group.
d Dunnet control group comparison test with the positive control as a control group.
(** p < 0.01; * p < 0.05; p > 0.05 Ð not significant).
Significant differences in the percentage of ab-
errant mitosis of the studied samples, the types of
chromosome aberrations and time-dependant ef-
fects after treatment were observed. The dichloro-
methane extract showed the highest clastogenic ef-
fect. Relatively high percentage of aberrations was
found also for the methanol extract, the sterol
fraction and luteolin 7-O-glucoside. Both, the
water extract and its low-molecular water fraction,
produced low percentage of aberrations.
The scored chromosome aberrations were pre-
dominantly breaks and centromeric-centromeric
fission (c/c) and more rarely fragments and te-
lomeric-telomeric fission (t/t). For example, frac-
tion B, the ethyl acetate and low molecular frac-
tions, and rutin caused only breaks and c/c fission;
the sterol fraction gave also fragments; the water
extract caused breaks, c/c and t/t fissions.
Time-dependent frequencies of the aberrant
metaphases were observed. The effect of the crude
extracts and fractions (except fraction B) followed
the relationship observed for MMC, lower values
at 48 h vs. 24 h after dosing. Fraction B and the
individual compounds caused increasing in the
aberrant mitosis 48 h after administering. It could
be presumed that the studied glycosides (α-bisabo-
lol fucopyranoside, luteolin 7-O-glucoside and ru-
tin) metabolize in the mouse organism to the cor-
responding aglycones or other metabolites with
stronger clastogenic effects. For example, rutin did
not damage the chromosomes after 24 h, but after
48 h caused a significant increase of aberrant mito-
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sis (Table I, p < 0.01). Rutin metabolizes to quer-
cetin, which is known to inhibit the growth of cells
in various human cancers (Yoshida et al., 1990; Ra-
nelletti et al., 1992; Scambia et al., 1991) and has
selective cytotoxicity in malignant cells (Jagadees-
waran et al., 2000).
In conclusion, all tested samples showed lower
percentage of aberrations vs. mitomycin C and in
this sense are less harmful for mammalian cells.
The water extract and the low-molecular water
fraction did not show a statistically significant
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which suggests that the plant does not pose a great
hazard when used as herbal medicine.
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